XORTX Therapeutics Inc 20-F for FY2023
XORTX Therapeutics Inc. (XRTX)
20-F
2024-05-10
For: 2023-12-31
View Original
Added on
April 05, 2026
About this 20-F
XORTX Therapeutics Inc filed this 20-F on May 10, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $2.16M
- compared with a net loss of $7.72M a year earlier
- Diluted EPS
- -$1.09
- compared with -$5.22 a year earlier